Drug Trial Radar · NCT07208591
To Evaluate The Safety and Efficacy of STSA-1002 Injection in Patients With Acute Respiratory Distress Syndrome
Last checked: Nov 19, 2026Latest source record: Jan 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
406
Planned (sponsor's estimate)
Start
Oct 31, 2025
Primary completion
Jul 2026
Study completion Oct 2026
Sponsor
- Lead sponsor
- Staidson (Beijing) Biopharmaceuticals Co., LtdIndustry
- Sponsor type
- Industry
- First posted
- Oct 6, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To evaluate the efficacy, safety and tolerability of STSA-1002 injection in patients with acute respiratory distress syndrome
Conditions
- Acute Respiratory Distress Syndrome (ARDS)
Interventions
STSA-1002 injectionDrug
basal treatment + STASA-1002 intravenous infusion
STSA-1002 Injection PlaceboDrug
basal treatment + STSA-1002 Injection Placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- 28-day all-cause mortality rateTime frame: Day28 after first dose
Locations
15 sites in 1 country. Site status is shown where the registry gives one.
China-Japan Friendship Hospital
Beijing, Beijing Municipality, China · Recruiting
The First Affiliated Hospital of Xiamen University
Xiamen, Fujian, China · Recruiting
The Third Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong, China · Recruiting
The First Affiliated Hospital, Sun Yat-sen University
Guangzhou, Guangdong, China · Recruiting
The Affiliated Hospital of Zunyi Medical University
Zunyi, Guizhou, China · Recruiting
The First Affiliated Hospital of Henan University of Science and Technology
Luoyang, Henan, China · Recruiting
Henan Provincial People's Hospital
Zhengzhou, Henan, China · Recruiting
The First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, China · Recruiting
Wuhan Central Hospital
Wuhan, Hubei, China · Recruiting
Xiangtan Central Hospital
Xiangtan, Hunan, China · Recruiting
The First Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, China · Recruiting
Weifang People's Hospital
Weifang, Shandong, China · Recruiting
Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital
Chengdu, Sichuan, China · Recruiting
Dazhou Central Hospital
Dazhou, Sichuan, China · Recruiting
Hangzhou First People's Hospital
Hangzhou, Zhejiang, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.